Netherlands

The Netherlands earns its place in any caregiving atlas through ideas about how care is organized, not through machines. Its best-known export is Buurtzorg — "neighborhood care" — founded in 2006 by former nurse Jos de Blok. Instead of dispatchers and managers, Buurtzorg runs hundreds of small, self-managing teams of about ten to twelve nurses, each responsible for roughly fifty to sixty patients in one neighborhood. The teams handle their own scheduling, intake, and quality, and the model has been adapted in around 25 countries (Commonwealth Fund).

The second landmark is De Hogeweyk, the original "dementia village" that opened in Weesp in 2009. About 188 residents with severe dementia live in roughly two dozen small households matched to their former lifestyles, inside a walkable enclosure with a real square, shops, and a café. Carers wear ordinary clothes, and the design bets on normality and familiarity over a clinical environment.

Underneath these flagship models sits a three-part public system that makes long-term care broadly affordable: the Long-Term Care Act (Wlz) for intensive, around-the-clock care; the Social Support Act (Wmo) for municipally-organized home support with income-capped contributions; and district nursing funded through health insurance. Working family caregivers — "mantelzorgers" — have statutory short-term and emergency care leave plus the right to request flexible hours (Eurocarers). Informal care is enormous in scale: Dutch sources put the number of informal caregivers at roughly 5 million adults, several hundred thousand of them seriously overburdened.

On technology, the honest picture is "useful, not futuristic." Remote screen-based care ("beeldzorg") and home sensors — passive fall detection, smart medication dispensers, personal alarms — are mainstream in district nursing and actively subsidized through the national SET e-health incentive scheme (Zorg voor Beter). AI companions and social robots like the much-studied ZORA exist mostly as pilots, with researchers candid about software failures and limited evidence of clinical benefit (Healthcare / PMC).

It's worth resisting the hype even about the good models. Buurtzorg's efficiency is real but its cost record is mixed — the 2012 KPMG analysis paired big reductions in care hours with higher downstream curative-care costs. De Hogeweyk cost north of €20 million, leaned on public funding, and has repeatedly stalled when others try to copy it abroad. And the wider system is under pressure: the 2015 reform that pushed people to age in place tightened nursing-home access and lengthened waits for those with dementia (J. Am. Geriatrics Society).

For a US caregiver, the takeaway is encouraging precisely because the most valuable Dutch ideas are organizational, not expensive. A small, consistent care team that knows the whole person; a reablement mindset that builds independence instead of just delivering tasks; and a few cheap remote check-ins — those are borrowable today, without waiting for a robot or a new law.